Synthetic method for preparing indole spiral cyclopentane derivant
A technology for the synthesis of indolespirocyclopentane, which is applied in the direction of organic chemistry, etc., can solve the problems of simple synthesis methods that are rarely reported, and achieve the effects of low cost, convenient operation, and good application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] The synthesis of embodiment 1 compound 3a
[0016]
[0017] (E)-1-benzyl-3-(3-phenyl-2-propynyl)indolin-2-one (0.1mmol), 4-phenyl-3-butyn-2-one ( 0.2mmol) was dissolved in 1mL dichloromethane / ethyl acetate (9 / 1), and the catalyst PPh was added 3 (0.05mmol), reacted at room temperature for 48h, concentrated and separated by column chromatography to obtain the corresponding indole spirocyclopentane derivative 3a with a yield of 63%. IR(KBr): v=3059, 3028, 1718, 1690, 1619, 1588, 1447, 1362, 1184, 1168, 908, 870, 762, 696cm -1 . 1 H NMR (500MHz, CDCl 3 )δ7.82 (s, 1H), 7.35-7.27 (m, 3H), 7.24-7.21 (m, 3H), 7.16-7.05 (m, 7H), 6.97 (t, J=8.0Hz, 2H), 6.89 -6.86(m, 2H), 6.82(d, J=7.5Hz, 2H), 6.78(d, J=8.0Hz, 1H), 5.08(d, J=16.0Hz, 1H), 4.36(d, J= 16.0Hz, 1H), 3.85(dd, J=11.5, 7.5Hz, 1H), 3.16(dd, J=13.0, 8.0Hz, 1H), 2.98(dd, J=13.0, 6.5Hz, 1H). 13 C NMR (125MHz, CDCl 3 )δ202.44,175.67,142.82,138.63,136.17,135.24,134.25,131.74,130.99,129.74,129.37,129.04,128.80,128.30,...
Embodiment 2
[0018] The synthesis of embodiment 2 compound 3b
[0019]
[0020] (E)-1-benzyl-5-chloro-3-(3-phenyl-2-propynyl)indolin-2-one (0.1mmol), 4-phenyl-3-butyne- 2-Kone (0.2mmol) was dissolved in 1mL dichloromethane / ethyl acetate (9 / 1), catalyst PPh3 (0.05mmol) was added, reacted at room temperature for 48h, concentrated and separated by column chromatography to obtain the corresponding indolespirocyclopentadiene Alkane derivative 3b, yield 72%. 1 H NMR (300MHz, CDCl 3 )δ7.84 (s, 1H), 7.24 (d, J=2.1Hz, 2H), 7.23-7.19 (m, 2H), 7, 19-7.17 (m, 2H), 7.17-7.01 (m, 6H) , 7.00-6.94(m, 2H), 6.80(d, J=7.2Hz, 2H), 6.68(d, J=8.3Hz, 1H), 5.04(d, J=15.8Hz, 1H), 4.37(d, J=15.8Hz, 1H), 3.83(dd, J=10.8, 8.0Hz, 1H), 3.21(dd, J=18.0, 8.0Hz, 1H), 2.96(dd, J=18.0, 10.8Hz, 1H). 13 C NMR (75MHz, CDCl 3 )δ201.97,174.42,166.50,154.59,148.63,141.49,141.37,139.20,135.41,135.22,134.79,134.05,133.99,133.08,132.16,131.74,130.04,129.89,129.25,129.16,129.02,128.93,128.90,128.70 ,128.60,128.52,128.40,128....
Embodiment 3
[0021] The synthesis of embodiment 3 compound 3c
[0022]
[0023] (E)-1-benzyl-5-chloro-3-(3-phenyl-2-propynyl)indolin-2-one (0.1mmol), 4-phenyl-3-butyne- 2-Kone (0.2mmol) was dissolved in 1mL dichloromethane / ethyl acetate (9 / 1), catalyst PPh3 (0.05mmol) was added, reacted at room temperature for 48h, concentrated and separated by column chromatography to obtain the corresponding indolespirocyclopentadiene Alkane derivative 3c, yield 58%. IR(KBr): v=3057, 3030, 2920, 2852, 1731, 1718, 1617, 1558, 1541, 1508, 1490, 1455, 1450, 1186, 1175, 861, 758, 694cm -1 . 1 H NMR (300MHz, CDCl 3)δ7.84 (s, 1H), 7.28-7.17 (m, 6H), 7.14-7.02 (m, 5H), 6.99-6.92 (m, 4H), 6.81 (d, J=7.2Hz, 2H), 6.68 (dd, J=9.3, 4.2Hz, 1H), 5.06(d, J=15.9Hz, 1H), 4.37(d, J=15.9Hz, 1H), 3.85(dd, J=11.1, 8.1Hz, 1H) , 3.21(dd, J=18.0, 8.1Hz, 1H), 2.95(dd, J=18.0, 11.1Hz, 1H). 13 C NMR (75MHz, CDCl 3 )δ201.98,175.56,160.92,139.18,138.88,135.52,134.98,134.03,131.72,129.86,129.37,129.23,128.92,128.69,128.49,1...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 